Timely insights and legal commentary on various health care issues and developments surrounding regulations, employment, transactions and a range of key industry matters. This blog is maintained by the Health Care Department of Stevens & Lee.
Health care providers and others in health care contemplating merger and other transactions subject to FTC review should be ready for significant implications arising from Axon Enterprise, Inc. v. Federal Trade Commission.
President Biden has prioritized strengthening and expanding the Pediatric Mental Health Care Access Awards program, according to the Secretary of the United States Department of Health and Human Services.
Many of the steps are straightforward and expected, but it is important that you understand the commitment of time necessary to finally get that receipt from the NY Department of State that the entity is officially dissolved.
The FDA has recently made efforts to encourage more diversity and equity in clinical trials by releasing “Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials.”
Judge Jeremy Kernodle of the U.S. District Court for the Eastern District of Texas decided to throw out another portion of the “No Surprise Act” in Lifenet, Inc., v. United States Department of Health and Human Services